HKD 0.49
(0.0%)
Year | Eps | Eps Growth |
---|---|---|
2023 | -0.27 HKD | 10.0% |
2022 | -0.30 HKD | 3.23% |
2021 | -0.31 HKD | -462.57% |
2020 | 0.09 HKD | 110.43% |
2019 | -0.82 HKD | -1071.56% |
2018 | 0.08 HKD | 968.35% |
2017 | 0.01 HKD | -94.36% |
2016 | 0.14 HKD | -6.67% |
2015 | 0.15 HKD | -99.8% |
2014 | 74.54 HKD | 0.0% |
2013 | - HKD | 0.0% |
Year | Eps | Eps Growth |
---|---|---|
2024 Q2 | -0.05 HKD | 72.18% |
2023 Q2 | -0.10 HKD | 52.3% |
2023 FY | - HKD | 10.0% |
2023 Q4 | -0.17 HKD | -78.2% |
2022 FY | - HKD | 3.23% |
2022 Q4 | -0.20 HKD | -100.0% |
2022 Q2 | -0.10 HKD | 70.59% |
2021 Q2 | 0.03 HKD | -41.09% |
2021 FY | - HKD | -462.57% |
2021 Q4 | -0.34 HKD | -1218.42% |
2020 Q2 | 0.03 HKD | 104.97% |
2020 FY | - HKD | 110.43% |
2020 Q4 | 0.05 HKD | 57.32% |
2019 FY | - HKD | -1071.56% |
2019 Q2 | -0.17 HKD | -659.21% |
2019 Q4 | -0.66 HKD | -288.24% |
2018 FY | - HKD | 968.35% |
2018 Q4 | 0.03 HKD | -43.7% |
2018 Q2 | 0.05 HKD | 281.21% |
2017 Q2 | 0.04 HKD | -64.09% |
2017 Q4 | -0.03 HKD | -175.44% |
2017 FY | - HKD | -94.36% |
2016 FY | - HKD | -6.67% |
2016 Q2 | 0.04 HKD | -76.94% |
2016 Q4 | 0.11 HKD | 198.1% |
2015 Q2 | -0.04 HKD | -134.62% |
2015 FY | - HKD | -99.8% |
2015 Q4 | 0.16 HKD | 455.56% |
2014 Q4 | 0.13 HKD | -99.02% |
2014 FY | - HKD | 0.0% |
2014 Q2 | 13.23 HKD | -24.91% |
2013 FY | - HKD | 0.0% |
2013 Q4 | 17.62 HKD | 0.0% |
Name | Eps | Eps Difference |
---|---|---|
Pak Fah Yeow International Limited | 0.34 HKD | 179.412% |
Grand Pharmaceutical Group Limited | 0.54 HKD | 150.0% |
Extrawell Pharmaceutical Holdings Limited | -0.07 HKD | -295.894% |
Wai Yuen Tong Medicine Holdings Limited | -0.01 HKD | -1976.923% |
Qianhai Health Holdings Limited | -0.03 HKD | -768.167% |
Lee's Pharmaceutical Holdings Limited | 0.03 HKD | 1050.704% |
Essex Bio-Technology Limited | 0.49 HKD | 155.102% |
Tongfang Kontafarma Holdings Limited | -0.01 HKD | -5092.308% |
SSY Group Limited | 0.44 HKD | 161.364% |
JBM (Healthcare) Limited | 0.15 HKD | 280.0% |
Jacobson Pharma Corporation Limited | 0.12 HKD | 325.0% |
China Resources Pharmaceutical Group Limited | 0.68 HKD | 139.706% |